Senti Biosciences, Inc. (SNTI) Insider Trading Activity

NASDAQ$0.1723-0.01 (-5.62%)
Market Cap
$5.54M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
778 of 849
Rank in Industry
448 of 491

SNTI Insider Trading Activity

SNTI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Senti Biosciences, Inc.

Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings. Their proprietary synthetic biology platform leverages readily available, "off-the-shelf" chimeric antigen receptor natural killer (CAR-NK) …

Insider Activity of Senti Biosciences, Inc.

Over the last 12 months, insiders at Senti Biosciences, Inc. have bought $0 and sold $0 worth of Senti Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Senti Biosciences, Inc. have bought $0 and sold $24,413 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 800 shares for transaction amount of $3,320 was made by Browne Leslie J (President and CEO) on 2013‑12‑19.

List of Insider Buy and Sell Transactions, Senti Biosciences, Inc.

2025-02-06SaleLu Timothy KCEO
545
0.011%
$4.36
$2,376
-52.66%
2025-02-06SaleRajangam KanyaPres. & Chief Med. & Dev. Off.
182
0.0037%
$4.37
$795
-52.66%
2025-02-04SaleLu Timothy KCEO
3,922
0.0753%
$4.07
$15,963
-46.89%
2025-02-04SaleRajangam KanyaPres. & Chief Med. & Dev. Off.
1,297
0.0249%
$4.07
$5,279
-46.89%
2013-12-19PurchaseBrowne Leslie JPresident and CEO
800
0.0335%
$4.15
$3,320
2013-05-20PurchaseBrowne Leslie JPresident and CEO
30,000
0.0121%
$0.04
$1,200
Total: 6

SNTI Institutional Investors: Active Positions

Increased Positions8+42.11%138,655+2.36%
Decreased Positions7-36.84%387,460-6.61%
New Positions4New123,102New
Sold Out Positions5Sold Out379,044Sold Out
Total Postitions20+5.26%6M-4.24%

SNTI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nea Management Company, Llc$4,153.0014.52%3.78M00%2025-09-30
Nantahala Capital Management, Llc$977.003.42%888,00000%2025-09-30
Vanguard Group Inc$678.002.37%616,073+255,162+70.7%2025-09-30
8Vc Gp I, Llc$279.000.98%253,75500%2025-09-30
Geode Capital Management, Llc$168.000.59%152,838+5,524+3.75%2025-09-30
Citadel Advisors Llc$91.000.32%82,753+82,753New2025-09-30
Xtx Topco Ltd$29.000.1%26,567+26,567New2025-09-30
Blackrock, Inc.$25.000.09%22,604+520+2.35%2025-09-30
Northern Trust Corp$18.000.06%16,310+16,310New2025-09-30
Two Sigma Investments, Lp$18.000.06%15,968+15,968New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.